Leprosy and Gastrointestinal inflammation
Gastrointestinal inflammation is reported only by a few people with Leprosy.
The study analyzes which people have Gastrointestinal inflammation with Leprosy. It is created by eHealthMe based on 2 people who have Gastrointestinal inflammation and Leprosy from the Food and Drug Administration (FDA), and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2 people who have Leprosy and Gastrointestinal Inflammation are studied.
What is Leprosy?
Leprosy (a disfiguring disease caused by the mycobacterium leprae bacteria) is found to be associated with 118 drugs and 81 conditions by eHealthMe.
What is Gastrointestinal inflammation?
Gastrointestinal inflammation (inflammation of stomach and intestine) is found to be associated with 773 drugs and 511 conditions by eHealthMe.
Number of Gastrointestinal inflammation in Leprosy reports submitted per year:
Gender of people who have Leprosy and experienced Gastrointestinal Inflammation *:
- female: 0.0 %
- male: 100 %
Age of people who have Leprosy and experienced Gastrointestinal Inflammation *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 100 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common drugs taken by these people *:
- Dapsone: 1 person, 50.00%
Common symptoms for these people *:
- Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 2 people, 100.00%
- Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 2 people, 100.00%
- Hyperglobulinaemia (abnormally large amounts of globulins in the blood): 2 people, 100.00%
- Histiocytosis (a blood disease characterized by an abnormal multiplication of macrophages): 2 people, 100.00%
- Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 100.00%
- Eosinophilia (eosinophil count in the peripheral blood exceeds): 2 people, 100.00%
- Abdominal Pain: 2 people, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Gastrointestinal inflammation?Check whether Gastrointestinal inflammation is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Schwerd T, Pandey S, Yang HT, Bagola K, Jameson E, Jung J, Lachmann RH, Shah N, Patel SY, Booth C, Runz H, "Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann–Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn9s disease", Gut, 2016 Mar .
Treatments, associated drugs and conditions:
COVID vaccines that are related to Gastrointestinal inflammation:
- Gastrointestinal inflammation in Moderna COVID Vaccine
- Gastrointestinal inflammation in Pfizer BioNTech Covid Vaccine
- Gastrointestinal inflammation in Johnson and Johnson Covid Vaccine
Common drugs associated with Gastrointestinal inflammation:
All the drugs that are associated with Gastrointestinal inflammation:
- Gastrointestinal inflammation (773 drugs)
Common conditions associated with Gastrointestinal inflammation:
All the conditions that are associated with Gastrointestinal inflammation:
- Gastrointestinal inflammation (511 conditions)
How the study uses the data?
The study is based on Gastrointestinal inflammation and Leprosy, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Selenium Sulfide and Lovenox drug interaction - now
- Sumatriptan and Briviact drug interaction - a second ago
- Miralax and Escherichia Infection - 2 seconds ago
- Triamcinolone and Levothroid drug interaction - 3 seconds ago
- Spironolactone and Evoxac drug interaction - 7 seconds ago
- Vincristine Sulfate and Gastrointestinal Tract Adenoma - 11 seconds ago
- Rebif and Color Blindness - 20 seconds ago
- Fentanyl Citrate and Nodule - 20 seconds ago
- Simcor vs. Fluvastatin - 23 seconds ago
- Azelastine Hydrochloride and Msm drug interaction - 25 seconds ago